Allergic Contact Dermatitis

Dermatology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Edesa Biotech
Edesa BiotechON - Markham
1 program
1
EB01 Cream PlaceboPhase 21 trial
Active Trials
NCT03680131Completed211Est. Jan 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Edesa BiotechEB01 Cream Placebo

Clinical Trials (1)

Total enrollment: 211 patients across 1 trials

NCT03680131Edesa BiotechEB01 Cream Placebo

Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact Dermatitis

Start: Oct 2019Est. completion: Jan 2023211 patients
Phase 2Completed

Related Jobs in Dermatology

MSL/Senior MSL, Dermatology - Tampa, Florida

AbbVie
Remote
13h ago

(Senior) Außendienstmitarbeiter Dermatology (all genders) - Region Thüringen

AbbVie
Remote
13h ago

Regional Sales Trainer - Dermatology (Central / West Regions)

AbbVie
Remote
14h ago

Regional Sales Trainer - Dermatology (Northeast / Southeast Regions)

AbbVie
Remote
14h ago

Delegado Especialista Ventas Dermatología (Inmunología)

AbbVie
Remote
18h ago

Senior Manager, HTA, Value and Evidence (HV&E), Medical Dermatology

Pfizer
United States - New York - New York City
Yesterday
$139K - $232K/yr

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

Related Indications

Dermatitis, Atopic(42)Hidradenitis Suppurativa(30)Chronic Spontaneous Urticaria(21)Alopecia Areata(17)Hidradenitis Suppurativa (HS)(10)Vitiligo(9)Rosacea(6)Chronic Urticaria(5)Pruritus(5)Androgenetic Alopecia(5)